The purpose of this study was to prospectively compare the diagnostic performance of18F-AlF-PSMA-11 and68Ga-PSMA-11 in the detection of metastasis in patients with intermediate-/high-risk PCa at initial staging prior to therapy and their potential impact on patient management. The gene discussed is FOLH1; the disease is posterior cortical atrophy.